Literature DB >> 6146410

Associations between serum gamma-glutamyltransferase and apolipoproteins: relationships with hepatobiliary diseases.

Y Artur, M Wellman-Bednawska, A Jacquier, G Siest.   

Abstract

We studied the association between gamma-glutamyltransferase (GGT) and apolipoproteins A or B in serum of 42 patients with various hepatobiliary diseases. Binding of the enzyme to apolipoprotein A is not related to a clearly defined disease, but appears to be mainly influenced by the ratio of total cholesterol to GGT activity. An important fraction of GGT activity is associated with apolipoprotein B in patients with icteric or anicteric cholestasis. Conversely, in noncholestatic patients, the percentage of apolipoprotein B-bound GGT activity is low. Addition of the "heavy" form of GGT, obtained by solubilizing the membrane-bound enzyme with detergents, to a serum with low GGT activity led to the binding of the enzyme only to apolipoprotein A. The "light" form of GGT, obtained by limited proteolysis of the "heavy" form and added to the same serum, did not bind to either apolipoprotein A or apolipoprotein B. Thus, the association between the serum enzyme and apolipoprotein A apparently results from nonspecific aggregation of the amphiphilic "heavy" form of the enzyme. The origin of the apolipoprotein B-GGT complexes found in cholestatic patients needs further investigation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6146410

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  2 in total

1.  Alkaline phosphatase isoenzyme activities in rheumatoid arthritis: hepatobiliary enzyme dissociation and relation to disease activity.

Authors:  S Aida
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

2.  Interactive effects of a common γ-glutamyltransferase 1 variant and low high-density lipoprotein-cholesterol on diabetic macro- and micro-angiopathy.

Authors:  Hideaki Jinnouchi; Kazunori Morita; Takahiro Tanaka; Ayami Kajiwara; Yuki Kawata; Kentaro Oniki; Junji Saruwatari; Kazuko Nakagawa; Koji Otake; Yasuhiro Ogata; Akira Yoshida; Seiji Hokimoto; Hisao Ogawa
Journal:  Cardiovasc Diabetol       Date:  2015-05-08       Impact factor: 9.951

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.